JP2010529957A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529957A5
JP2010529957A5 JP2010510418A JP2010510418A JP2010529957A5 JP 2010529957 A5 JP2010529957 A5 JP 2010529957A5 JP 2010510418 A JP2010510418 A JP 2010510418A JP 2010510418 A JP2010510418 A JP 2010510418A JP 2010529957 A5 JP2010529957 A5 JP 2010529957A5
Authority
JP
Japan
Prior art keywords
glu
group
lys
asp
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010510418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529957A (ja
JP5358564B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/064177 external-priority patent/WO2008150689A1/en
Publication of JP2010529957A publication Critical patent/JP2010529957A/ja
Publication of JP2010529957A5 publication Critical patent/JP2010529957A5/ja
Application granted granted Critical
Publication of JP5358564B2 publication Critical patent/JP5358564B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010510418A 2007-05-30 2008-05-20 環状ペプチドｃｘｃｒ４アンタゴニスト Expired - Fee Related JP5358564B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94080207P 2007-05-30 2007-05-30
US60/940,802 2007-05-30
US94099607P 2007-05-31 2007-05-31
US60/940,996 2007-05-31
PCT/US2008/064177 WO2008150689A1 (en) 2007-05-30 2008-05-20 Cyclic peptide cxcr4 antagonists

Publications (3)

Publication Number Publication Date
JP2010529957A JP2010529957A (ja) 2010-09-02
JP2010529957A5 true JP2010529957A5 (enExample) 2011-07-07
JP5358564B2 JP5358564B2 (ja) 2013-12-04

Family

ID=39831600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010510418A Expired - Fee Related JP5358564B2 (ja) 2007-05-30 2008-05-20 環状ペプチドｃｘｃｒ４アンタゴニスト

Country Status (32)

Country Link
US (3) US7691813B2 (enExample)
EP (2) EP2160221B1 (enExample)
JP (1) JP5358564B2 (enExample)
KR (2) KR101169846B1 (enExample)
CN (1) CN101678213B (enExample)
AR (1) AR066648A1 (enExample)
AT (1) ATE516853T1 (enExample)
AU (1) AU2008260326B2 (enExample)
BR (1) BRPI0812134A2 (enExample)
CA (1) CA2688574C (enExample)
CL (1) CL2008001467A1 (enExample)
CO (1) CO6241137A2 (enExample)
CR (1) CR11105A (enExample)
CY (1) CY1111815T1 (enExample)
DK (1) DK2160221T3 (enExample)
DO (1) DOP2009000270A (enExample)
EA (1) EA017716B1 (enExample)
GT (1) GT200900304A (enExample)
HR (1) HRP20110551T1 (enExample)
IL (1) IL201685A (enExample)
JO (1) JO2776B1 (enExample)
MA (1) MA31666B1 (enExample)
MX (1) MX2009012952A (enExample)
MY (1) MY149432A (enExample)
NZ (1) NZ580849A (enExample)
PE (1) PE20090299A1 (enExample)
PL (1) PL2160221T3 (enExample)
PT (1) PT2160221E (enExample)
TN (1) TN2009000496A1 (enExample)
TW (1) TWI423987B (enExample)
WO (1) WO2008150689A1 (enExample)
ZA (1) ZA200908345B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2942798B1 (fr) * 2009-03-05 2011-04-08 Centre Nat Rech Scient Peptides utilisables pour le traitement de la leucemie lymphoide chronique
IT1397901B1 (it) * 2010-01-26 2013-02-04 Consiglio Nazionale Ricerche Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico.
WO2012118124A1 (ja) * 2011-03-01 2012-09-07 国立大学法人京都大学 新規ケモカイン受容体拮抗剤
MX343205B (es) * 2011-06-07 2016-10-28 Polyphor Ag Peptidomiméticos de horquilla beta como antagonistas de cxc4.
WO2013044500A1 (zh) * 2011-09-30 2013-04-04 Cheng Yun 丙型肝炎病毒免疫原性肽或其衍生物在预防或治疗关节炎中的应用
CA2852160A1 (en) 2011-10-28 2013-05-02 Galderma Research & Development New leukocyte infiltrate markers for rosacea and uses thereof
EP2979991A1 (en) 2014-07-31 2016-02-03 Greif International Holding BV. Multilayer material, fire protection mat with said multilayer material and transport and storage container assembly comprising said fire protection mat.
ES2764840T3 (es) 2015-01-28 2020-06-04 Univ Bordeaux Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
WO2017176565A1 (en) 2016-04-07 2017-10-12 Eli Lilly And Company Combinations of an anti-b7-h1 antibody and a cxcr4 peptide antagonist for treating a solid tumor
EP3509612A4 (en) * 2016-09-06 2021-07-21 Mainline Biosciences CXCR4 ANTAGONISTS AND METHOD OF USE
CN106841624B (zh) * 2017-01-26 2019-02-22 庄磊靓 抗人cd4和抗人cd184单克隆抗体作为标志物的应用
KR20200043970A (ko) * 2017-09-05 2020-04-28 메인라인 바이오사이언스 고친화성 cxcr4 선택적 결합 콘쥬게이트 및 그 사용 방법
US11123437B2 (en) * 2017-09-05 2021-09-21 Mainline Biosciences, Inc. Selective CXCR4 binding peptide conjugate and methods for making and using the same
US11771736B2 (en) * 2017-12-21 2023-10-03 Mainline Biosciences (Shanghai) Co., Ltd. Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
JP2021165234A (ja) * 2018-07-03 2021-10-14 富士フイルム富山化学株式会社 Ｃｘｃｒ４結合性化合物もしくはその塩またはそれらと金属との錯体
EP3849997B1 (en) 2018-09-12 2024-05-01 Technische Universität München Cxcr4-targeted diagnostic and therapeutic agents with reduced species selectivity
EA202190755A1 (ru) 2018-09-12 2021-06-11 Технише Универзитет Мюнхен Агенты для терапии и диагностики рака
WO2020210919A1 (en) * 2019-04-18 2020-10-22 Provincial Health Services Authority Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy
EP4097120A4 (en) * 2020-01-26 2024-05-01 Mainline Biosciences (Shanghai) Co., Ltd. ISOTOPE-LABELED CXCR4 SELECTIVELY BINDING PEPTIDE CONJUGATE AND METHODS OF MAKING AND USE THEREOF
WO2022082312A1 (en) * 2020-10-21 2022-04-28 Provincial Health Services Authority Novel cxcr4-targeting compounds
CN116615411A (zh) * 2020-12-25 2023-08-18 中外制药株式会社 包含n-取代氨基酸残基的肽化合物的制造方法
WO2022138891A1 (ja) * 2020-12-25 2022-06-30 中外製薬株式会社 Ｎ－置換－アミノ酸残基を含むペプチド化合物の製造方法
EP4043041A1 (en) 2021-02-15 2022-08-17 Technische Universität München Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof
JP2025513489A (ja) * 2022-04-20 2025-04-24 プロビンシャル・ヘルス・サービシーズ・オーソリティ Ｃｘｃｒ４標的化合物、およびその作製方法、およびその使用方法
CN115060901A (zh) * 2022-06-21 2022-09-16 中国医学科学院基础医学研究所 苹果酸酶2在制备矽肺病或肺纤维化相关疾病诊断试剂或治疗药物中的应用
WO2025218761A1 (zh) * 2024-04-17 2025-10-23 晶核生物医药科技(上海)有限公司 环状肽类化合物、其药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4391123B2 (ja) * 2002-10-24 2009-12-24 株式会社オーファンリンク 新規ｃｘｃｒ４アンタゴニスト
US8628750B2 (en) * 2006-02-27 2014-01-14 Technische Universitat Munchen Cancer imaging and treatment

Similar Documents

Publication Publication Date Title
JP2010529957A5 (enExample)
US20240209026A1 (en) A4b7 thioether peptide dimer antagonists
AU2018387418B2 (en) Bicyclic peptide ligands specific for EphA2
HRP20110551T1 (hr) Antagonisti cikličkog peptida cxcr4
JP2012530145A5 (enExample)
NZ601175A (en) Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
JP2017535527A5 (enExample)
JP2011518179A5 (enExample)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
JP2009537563A5 (enExample)
JP2011522795A5 (enExample)
WO2004064787A3 (en) Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
US10632187B2 (en) Hemagglutinin-binding peptide
JPWO2020230780A5 (enExample)
JP2006503088A5 (enExample)
EP2686019B1 (en) Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids
EP0640618B1 (de) Tetrahydronaphthalin-Peptidderivate
WO2008070049A8 (en) Peptide and treatment for hiv-1 infection
JP2009507077A5 (enExample)
EP3220957B1 (en) Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to an anionic polypeptide for the treatment of aids
JP2014515751A5 (enExample)
WO2025137159A1 (en) Human interleukin (il)-17 cytokine binding peptides
WO2018035615A1 (en) Compositions and methods for the treatment of inflammatory bowel diseases
JPH0925240A (ja) 医薬組成物
HK1247220A1 (zh) 环状甘丙肽类似物及其用途